Statements (28)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
disambiguation term
|
| gptkbp:associatedWith |
gptkb:public_policy
pharmaceutical industry lobbying drug pricing |
| gptkbp:connotation |
negative
|
| gptkbp:criticizedFor |
marketing practices
high drug prices influence on regulation intellectual property practices profit motives |
| https://www.w3.org/2000/01/rdf-schema#label |
Big Pharma
|
| gptkbp:perceivedAs |
secretive
powerful profit-driven |
| gptkbp:refersTo |
large pharmaceutical companies
|
| gptkbp:relatedTo |
public health
medical innovation drug development access to medicine |
| gptkbp:subjectOf |
gptkb:media
conspiracy theories academic research |
| gptkbp:usedIn |
public discourse
|
| gptkbp:bfsParent |
gptkb:Klabater
gptkb:Daniel_Monkman gptkb:Big_Shampoo |
| gptkbp:bfsLayer |
8
|